Paxlovid cuts seniors’ COVID-19 risk, no matter their vaccine status: study
By
Alicia Lasek (f3)
Jun 03, 2022
Both vaccinated and unvaccinated seniors with COVID-19 have lower rates of hospitalization and death when taking the antiviral pill Paxlovid, according to a new study from Israel.
New FDA initiative seeks to boost clinicians’ dietary supplements knowledge
By
Alicia Lasek (f3)
Jun 03, 2022
Educational supports for healthcare providers include a continuing education program on the benefits and risks of dietary supplements.
Clinical briefs for Friday, June 3
By
Alicia Lasek (f3)
Jun 03, 2022
‘Catastrophic’ changes to blood cells may explain sudden frailty in older age … Pulse oximeter failures delayed COVID care for dark-skinned patients … Second half of life focuses on quality...
Geriatricians weigh value of newer advance care directives for nursing home residents
By
Alicia Lasek (f3)
Jun 02, 2022
In a new editorial, specialists ask whether Physician Orders for Life-Sustaining Treatment lead to high-quality care for residents.
Slowed walking tied to dementia risk
By
Alicia Lasek (f3)
Jun 02, 2022
Seniors with cognitive decline whose walking speed slows over time are more likely to develop dementia, a new study finds.
Clinical briefs for Thursday, June 2
By
Alicia Lasek (f3)
Jun 02, 2022
Some docs reconsider Paxlovid use for mild COVID-19 cases … Department of Labor releases new guidance and FAQs on mental health leave … Redefine long COVID in seniors as a “geriatric syndrome,”...
Alternatives to antipsychotics can create new dangers, study finds
By
Alicia Lasek (f3)
Jun 01, 2022
Fewer residents with dementia now receive off-label antipsychotic drugs in VA nursing facilities. But overreliance on other behavior-modifying medications has spiked, a new study finds.
Aduhelm’s costs: Medicare recipients won’t get premium reduction until 2023
By
Alicia Lasek (f3)
Jun 01, 2022
A cost overestimate that bumped up Medicare premiums for seniors in 2022 will not be corrected until the following year. The spike is tied to coverage for Alzheimer’s drug Aduhelm.
These risk factors signal high mortality in multidrug-resistant infections: study
By
Alicia Lasek (f3)
Jun 01, 2022
Patients with multiple comorbidities and positive blood cultures have higher odds of mortality when diagnosed with certain common bacterial infections, investigators say.
Clinical briefs for Wednesday, June 1
By
Alicia Lasek (f3)
Jun 01, 2022
After leading in COVID-19 drug trials, a nursing home chain now partners on dementia drug … FDA extends shelf life of COVID-19 antibody bebtelovimab 6 more months … Memory often returns following a...